Syndivia's vision is to deliver the best treatment to cancer patients by harnessing unique properties of tumour hallmarks and microenvironment.
Location: France, Grand Est, Strasbourg
Employees: 1-10
Total raised: $2.56M
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | Capital Gr... | capitalgra... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 10.03.2020 | - | $2.26M | - |
| 21.07.2015 | Grant | $300.57K | - |
Mentions in press and media 2
| Date | Title | Description |
| 13.03.2020 | Biotech startup Syndivia scores €2M | Syndivia, a France-based developer of treatments for solid cancers, has secured a €2 million investment from Bpifrance. The proceeds of the round will go toward funding the advancement of the company's drug candidate toward clinical trials.... |
| 10.03.2020 | Syndivia Raises €2m in Financing | Syndivia, a Strasbourg, France-based research-driven biotechnology company focused on the development of new therapeutic modalities for cancers, raised €2m in deep tech financing from Bpifrance. The proceeds will be used to further fund the... |